Serum antibody response to Chlamydia trachomatis TroA and HtrA in women with tubal factor infertility
File(s)Manuscript_EJCM.docx (40.8 KB)
Accepted version
Author(s)
Type
Journal Article
Abstract
Persistent genital chlamydial infection may lead to tubal factor infertility (TFI). Chlamydia trachomatis TroA and HtrA are proteins expressed during persistent chlamydial infection in vitro. We studied serum IgG antibody response against these proteins by EIA in women with TFI and in subfertile women without tubal pathology. Altogether, 22 of 258 subfertile women (8.5%) had TFI which was unilateral in 17 cases and bilateral in 5 cases. Overall, 55 (21.3%) of the 258 women had TroA and 39 (15.1%) had HtrA antibodies. Seropositivity to TroA and HtrA was more common among women with TFI than women with other causes for subfertility (45.5 vs. 19.1%, p = 0.004 for TroA; 36.4 vs. 13.1%, p = 0.004 for HtrA). Mean absorbance values and the prevalence of TroA and HtrA antibodies increased with increasing severity of TFI. On the basis of our results, TroA and HtrA serology has the potential to be further developed to a specific biomarker for C. trachomatis-related TFI.
Date Issued
2018-08-01
Date Acceptance
2018-05-09
Citation
European Journal of Clinical Microbiology and Infectious Diseases, 2018, 37 (8), pp.1499-1502
ISSN
0934-9723
Publisher
Springer Verlag
Start Page
1499
End Page
1502
Journal / Book Title
European Journal of Clinical Microbiology and Infectious Diseases
Volume
37
Issue
8
Copyright Statement
© 2018 Springer-Verlag GmbH Germany, part of Springer Nature. The final publication is available at Springer via https://link.springer.com/article/10.1007%2Fs10096-018-3276-9.
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/29777489
PII: 10.1007/s10096-018-3276-9
Subjects
Chlamydia trachomatis
HtrA
Persistent infection
Serology
TroA
Tubal factor infertility
Publication Status
Published
Coverage Spatial
Germany
Date Publish Online
2018-05-18